Transaction in Own Shares

Summary by AI BETAClose X

RTW Biotech Opportunities Ltd announced on September 24, 2025, that it repurchased 400,000 of its Ordinary Shares at $1.50 per share. These shares will be held in treasury. Following the transaction, the company's issued Ordinary Share capital is 345,967,440, with 17,393,791 shares held in treasury, resulting in total voting rights of 328,573,649. The buyback was executed under the authority granted at the Annual General Meeting in June 2025, allowing for repurchase of up to 14.99% of Ordinary Shares. The company intends to hold any repurchased Ordinary Shares in treasury.

Disclaimer*

UK 100

Latest directors dealings